This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Epic Pharma fails to dismiss US antitrust claims over Ursodiol

( March 2, 2026, 17:57 GMT | Official Statement) -- MLex Summary: Epic Pharma must face US antitrust claims accusing it of fixing prices for the drug Ursodiol, according to a federal judge. District Judge Cynthia M. Rufe said eight amended complaints sufficiently allege Epic conspired with co-defendants Lannett Company and Actavis20 to limit price competition for Ursodiol. Three complaints were dismissed because they supply no descriptions of Epic's actions beyond the fact that it sold a drug whose price increased by 1000%.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections